Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|October 3, 2007
Temozolomide in combination with fotemustine in patients with metastatic melanomaFaruk Tas, Hakan Camlica, Erkan Topuz
Japanese Journal of Clinical Oncology|October 25, 2006
Malignant melanoma in Turkey: a single institution's experience on 475 casesFaruk Tas, Sidika Kurul, Hakan Camlica, et al.
American Journal of Clinical Oncology|December 9, 2008
Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancerHakan Camlica, Derya Duranyildiz, Faruk Tas, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma: a single institution's experienceFaruk Tas, Sidika Kurul, Hakan Camlica, et al.
Diseases of the Colon and Rectum|March 13, 2009
The effect of glyceryl trinitrate ointment on posthemorrhoidectomy pain and wound healing: results of a randomized, double-blind, placebo-controlled studyHasan Karanlik, Remzi Akturk, Hakan Camlica, et al.
Melanoma Research|November 30, 2005
Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trialFaruk Tas, Andac Argon, Hakan Camlica, et al.
European Journal of Pain (London, England)|November 9, 2004
Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer painN Süleyman Ozyalçin, Gül Köknel Talu, Hakan Camlica, et al.
Medical Oncology (Northwood, London, England)|October 1, 2004
Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trialFaruk Tas, Cumhur Demir, Hakan Camlica, et al.
Oncology Letters|June 14, 2013
Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancerFaruk Tas, Fatma Sen, Nese Guney, et al.
Pathology Oncology Research : POR|March 19, 2008
The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancerHakan Camlica, Derya Duranyildiz, Hilal Oguz, et al.
Pageof 5